ECM
ZOM

ETrade Capital Management’s Zomedica Corp. ZOM Stock Holding History

ETrade Capital Management’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-14,091
Closed -$3K – 968
2020
Q2 		$3K Buy
+14,091
New +$2.68K ﹤0.01% 846

Other funds holding ZOM

Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ETrade Capital Management's ZOM Position: Q3 2020 in Review

ETrade Capital Management sold out of Zomedica Corp. (ZOM) in Q3 2020, closing a stake of 14,091 shares — an estimated $3K sold.

ETrade Capital Management first reported a position in ZOM in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 32 funds tracked by Wall St. Rank hold ZOM as of Q3 2020.

  • ETrade Capital Management reported no remaining Zomedica Corp. position as of Q3 2020 after selling out during the quarter.
  • ETrade Capital Management sold 14,091 Zomedica Corp. shares in Q3 2020, an estimated $3K.
  • ETrade Capital Management first reported a position in Zomedica Corp. in Q2 2020 and held it in 1 quarter.
  • ETrade Capital Management's Zomedica Corp. position peaked at $3K in Q2 2020.
  • 32 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.